AMENDMENT NO. 2 AND WAIVER2 and Waiver • March 19th, 2021 • Acutus Medical, Inc. • Surgical & medical instruments & apparatus • New York
This AMENDMENT NO. 2 AND WAIVER (this “Amendment”) is made and entered into as of October 21, 2020 by ORBIMED ROYALTY OPPORTUNITIES II, LP, in its capacity as Origination Agent and a Lender (each as defined in the Credit Agreement) under the Credit Agreement (as defined below) and DEERFIELD PRIVATE DESIGN FUND III, L.P., in its capacity as a Lender, in favor of ACUTUS MEDICAL, INC., a Delaware corporation (the “Borrower”) and acknowledged by WILMINGTON TRUST, NATIONAL ASSOCIATION, in its capacity as Administrative Agent (as defined in the Credit Agreement) under the Credit Agreement.
AMENDMENT NO. 2 AND WAIVER2 and Waiver • February 26th, 2010 • Corinthian Colleges Inc • Services-educational services
THIS AMENDMENT NO. 2 AND WAIVER (this “Amendment”), dated as of February 22 , 2010, is among HEALD REAL ESTATE, LLC, a Delaware limited liability company (the “Borrower”), HEALD CAPITAL, LLC, a Delaware limited liability company (“Holdings”), and BANK OF AMERICA, N.A. (the “Lender”).
Contract2 and Waiver • August 11th, 2021 • PERRIGO Co PLC • Pharmaceutical preparations • New York
This AMENDMENT NO. 2 AND WAIVER (this “Amendment No. 2”), dated as of August 10, 2021 and entered into by and among Perrigo Finance Unlimited Company, a public unlimited company organized under the laws of Ireland (the “Revolving Borrower”), Perrigo Company PLC, a public limited company organized under the laws of Ireland (the “Company”), each lender party hereto (each a “Consenting Lender” and, collectively, the “Consenting Lenders”) and JPMorgan Chase Bank, N.A., as administrative agent (in such capacity, the “Administrative Agent”), amends and is made pursuant to that certain Revolving Credit Agreement, dated as of March 8, 2018 (as amended by Amendment No. 1, dated as of August 15, 2019, and as further amended, restated, supplemented, waived or otherwise modified from time to time prior to the date hereof, the “Credit Agreement”), by and among the Revolving Borrower, the Company, the lenders from time to time party thereto, the Administrative Agent and the other agents party theret
AMENDMENT NO. 2 AND WAIVER2 and Waiver • August 16th, 2016 • 21st Century Oncology Holdings, Inc. • Services-offices & clinics of doctors of medicine • New York
This Amendment No. 2 and Waiver, dated as of August 15, 2016 (this “Amendment”), with respect to that certain credit agreement, dated as of April 30, 2015, among 21st Century Oncology, Inc., a Florida corporation (“Borrower”), 21st Century Oncology Holdings, Inc., a Delaware corporation (“Holdings”), the institutions from time to time party thereto as lenders, Morgan Stanley Senior Funding, Inc., as Administrative Agent and the other agents and arrangers named therein (as amended, supplemented or otherwise modified from time to time, the “Credit Agreement”), is entered into among Borrower, Holdings, the other Loan Parties and the Required Lenders. Capitalized terms used herein and not otherwise defined herein shall have the meanings ascribed to them in the Credit Agreement.
Contract2 and Waiver • November 14th, 2001 • Pw Eagle Inc • Miscellaneous plastics products • New York
AMENDMENT NO. 2 AND WAIVER (this "Amendment"), dated as of August 14, 2001, by and among PW EAGLE, INC., a Minnesota corporation (the "Company") and the investors party to the Purchase Agreement referred to below on the date hereof (the "Investors"). All capitalized terms used herein and not otherwise defined herein shall have the respective meanings provided such terms in the Purchase Agreement referred to below.
AMENDMENT NO. 2 AND WAIVER2 and Waiver • June 29th, 2007 • Leiner Health Products Inc • Pharmaceutical preparations • New York
AMENDMENT NO. 2 AND WAIVER (this “Amendment”), dated as of June 22, 2007, to that certain Credit Agreement, dated as of May 27, 2004, as amended by that certain Amendment No. 1 and Acknowledgement dated as of September 23, 2005 (the “Credit Agreement”), among LEINER HEALTH PRODUCTS INC., a Delaware corporation (“Borrower”), the Guarantor, the Subsidiary Guarantors, the Lenders, UBS SECURITIES LLC and MORGAN STANLEY SENIOR FUNDING, INC., as joint lead arrangers and joint book-runners (in such capacity, each an “Arranger”), MORGAN STANLEY SENIOR FUNDING, INC., as syndication agent (in such capacity, “Syndication Agent”), CREDIT SUISSE FIRST BOSTON, as documentation agent (in such capacity, “Documentation Agent”), UBS LOAN FINANCE LLC, as swingline lender (in such capacity, “Swingline Lender”), and UBS AG, STAMFORD BRANCH, as issuing bank (in such capacity, “Issuing Bank”), as administrative agent (in such capacity, “Administrative Agent”) for the Lenders and as collateral agent (in such
